NanoViricides is trading 5.6% lower at $1.36 on October 8, 2026, with no clear company-specific catalyst identified. - Shares pulled back from the October 7 close of $1.44. - Treasury yields and oil-related inflation concerns pressured broader markets, but supplied index moves were below the 0.5% threshold for attributing NanoViricides’ decline to the market. - The recent Ebola-trial update and October 7 investment conference presentation do not establish a catalyst for the drop.